March 24-26, 2023 – Banff, Alberta
CALL FOR ABSTRACTS
YOUNG INVESTIGATORS RESEARCH AWARDS PROGRAM
Deadline for submission January 6, 2023 (4pm central)
The CCOLD Young Investigators Research Awards Program aims to provide educational and research support to trainees interested in the area of lymphoproliferative (including plasma cell) disorders. Trainees at any level, confirmed by letter of training from their program director, are eligible to submit an abstract of their work. Abstracts presented at previous meetings, but not in full publication, are allowed for submission. All selected abstracts will be presented during a special Young Investigators Poster Session on the Saturday afternoon/evening at the CCOLD meeting in Banff Springs. All travel, hotel, and registration costs for attendance at the CCOLD meeting will be covered for Young Investigators selected for abstract presentation.
Deadline for submission January 6, 2023 (4pm central)
GUIDELINES AND ABSTRACT SUBMISSION
WELCOME TO CCOLD 2023
Please join us for the 13th Annual Canadian Conference on Lymphoproliferative Disorders (CCOLD) taking place as a hybrid conference in Banff, Alberta on March 24 to 26, 2023.
CCOLD provides a unique opportunity for attendees to interact with international experts in the field of hematologic malignancies. The scope of this meeting will highlight both recent research findings elucidating the pathophysiology of these diverse diseases, as well as changes in therapeutic advances that have had a large impact in the management of our patients. As in previous meetings the format will be didactic presentations as well as case based panel discussions. There will be opportunity for audience participation via keypad polling devices with the entire faculty featured during the panel discussions.
Internationally known researchers in Lymphoproliferative Disorders will provide keynote lectures and their perspectives on optimal management.
We will continue to support the “Young Investigators Research Awards Program” which has been very successful in providing educational and research support to trainees interested in Lymphoproliferative Disorders. Posters outlining their research will be focused at a special reception Saturday afternoon.
We look forward to seeing you at this educational event!
Yours truly,
CCOLD Co-Chairs
Dr. Wendy Lam, Burnaby, BC
Dr. Laurie Sehn, Vancouver, BC
On behalf of the CCOLD Planning Committee
Dr. Anca Prica, Toronto, ON
Dr. Pamela Skrabek, Winnipeg, MB
Dr. Carolyn Owen, Calgary, AB
Dr. Darrell White, Halifax, NS
Dr. Nathalie Johnson, Montreal, QC
Dr. Irwindeep Sandhu, Edmonton, AB
Dr. Julie Stakiw, Saskatoon, SK
TARGET AUDIENCE
This meeting has been designed to meet the educational needs of hematologists, oncologists, general practitioners in oncology and other health care providers involved in the management of patients with lymphoproliferative and plasma cell disorders.
LEARNING OBJECTIVES
Highlighting both recent research findings elucidating the pathophysiology of these diverse diseases, as well as changes in therapeutic advances that have had a large impact in the management of our patients.
A SPECIAL THANKS TO OUR AFFILIATES
COVID 19 GUIDELINES
While most COVID-19 restrictions have been lifted in Alberta, as health care professionals, we recognise that the COVID-19 pandemic is not over and we continue to be respectful of the risk of COVID-19 for vulnerable people. We ask that all meeting attendees be vaccinated against COVID-19 and to self-screen for COVID-19 symptoms. Do not attend any meetings if you have ILI-like symptoms. Please attempt to maintain physical distancing where possible and consider wearing a mask when not eating/drinking and/or where physical distancing is not possible.